37 th Annual Piper Sandler Healthcare Conference on Tuesday, December 2 nd at 1:30PM ET. Live audio of the events can be accessed by visiting the “Events” page of the company’s website at ...

Patients who received interscalene brachial plexus block plus soft tissue infiltration with Exparel when undergoing primary shoulder arthroplasty used significantly more narcotics postoperatively and ...

The Food and Drug Administration (FDA) has approved the use of Exparel (bupivacaine liposome injectable suspension; Pacira Pharmaceuticals) as an interscalene brachial plexus block to produce ...

Please provide your email address to receive an email when new articles are posted on . Use of liposomal bupivacaine in an interscalene nerve block effectively controlled pain after outpatient ...

— EXPAREL is the only FDA-approved single-dose regional analgesic to safely demonstrate four days of superiority versus bupivacaine in two clinical studies — — New indications for use as an adductor ...

TAMPA, Fla., March 29, 2023 (GLOBE NEWSWIRE) -- Pacira BioSciences, Inc. (PCRX), the industry leader in its commitment to non-opioid pain management and regenerative health solutions, today announced ...

Announcing a new article publication for BIO Integration journal. In this article the authors Daowei Lin, Zhixiao Han, Yanni Fu, Xiaoqiu Zhu, Jin Li, Hui Xu, Jing Wen, Fei Wang and Mingyan Guo from ...

Advances 5x30 strategy by expanding pipeline with a highly complementary asset that has the potential to provide several days ...

sNDA submission based on positive Phase 3 data supporting expansion of the EXPAREL label to include use in children aged six and over PARSIPPANY, N.J., Aug. 04, 2020 (GLOBE NEWSWIRE) -- Pacira ...

DUBAI, United Arab Emirates--(BUSINESS WIRE)--Prime Hospital, one of the UAE's leading healthcare service providers, has achieved another milestone by applying various innovative Anesthetic Techniques ...